APA (7th ed.) Citation

YQ, S., YC, W., L, W., HZ, R., YF, L., TH, Z., . . . YM, Z. (2026). Topical administration of GLP-1 eyedrops improves retinal ganglion cell function by facilitating presynaptic GABA release in early experimental diabetes. Neural regeneration research, 21(2), 800. https://doi.org/10.4103/NRR.NRR-D-24-00001

Chicago Style (17th ed.) Citation

YQ, Shao, Wang YC, Wang L, Ruan HZ, Liu YF, Zhang TH, Weng SJ, Yang XL, and Zhong YM. "Topical Administration of GLP-1 Eyedrops Improves Retinal Ganglion Cell Function by Facilitating Presynaptic GABA Release in Early Experimental Diabetes." Neural Regeneration Research 21, no. 2 (2026): 800. https://doi.org/10.4103/NRR.NRR-D-24-00001.

MLA (9th ed.) Citation

YQ, Shao, et al. "Topical Administration of GLP-1 Eyedrops Improves Retinal Ganglion Cell Function by Facilitating Presynaptic GABA Release in Early Experimental Diabetes." Neural Regeneration Research, vol. 21, no. 2, 2026, p. 800, https://doi.org/10.4103/NRR.NRR-D-24-00001.